• 1
    Wright TL, Lau JY. Clinical aspects of hepatitis B virus infection. Lancet 1993; 342: 13401344.
  • 2
    Blum HE, von Weizsacker F, Wieland S, Offensperger S, Offensperger W-B. Antiviral therapy of hepatitis B virus infection: blocking viral gene expression. Advanced Drug Delivery Reviews 1995; 17: 321331.
  • 3
    Offensperger W-B, Offensperger S, Walter E, Teubner K, Igloi G, Blum HE, Gerok W. In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides. EMBO J 1993; 12: 12571262.
  • 4
    von Weizsäcker F, Blum HE, Wands JR. Cleavage of hepatitis B virus RNA by three ribozymes transcribed from a single DNA template. Biochem Biophys Res Commun 1992; 189: 743748.
  • 5
    Carman W, Thomas H, Domingo E. Viral genetic variation: hepatitis B virus as a clinical example. Lancet 1993; 341: 349353.
  • 6
    Friedman AD, Triezenberg SJ, McKnight SL. Expression of a truncated trans-activator selectively impedes lytic infection by its cognate virus. Nature 1988; 335: 352354.
  • 7
    Trono D, Feinberg MB, Baltimore D. HIV-1 gag mutants can dominantly interfere with the replication of the wild-type virus. Cell 1989; 59: 113120.
  • 8
    Delaney MA, Goyal S, Seeger C. Design of modified core genes that inhibit replication of woodchuck hepatitis virus. In: HollingerFB, LemonSM, MargolisH. eds. Viral hepatitis and liver disease. Baltimore: Williams & Wilkins, 1991: 667668.
  • 9
    Horwich AL, Furtak K, Pugh J, Summers J. Synthesis of hepadnavirus particles that contain replication-defective duck hepatitis B virus genomes in cultured HuH-7 cells. J Virol 1990; 64: 642650.
  • 10
    Scaglioni PP, Melegari M, Wands JR. Characterization of hepatitis B virus core mutants that inhibit viral replication. Virology 1994; 205: 112120.
  • 11
    Crowther RA, Kiselev NA, Bottcher B, Berriman JA, Borisova GP, Ose V, Pumpens P. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 1994; 77: 943950.
  • 12
    Gallina A, Bonelli F, Zentilin L, Rindi G, Muttini M, Milanesi G. A recombinant hepatitis B core antigen polypeptide with the protamine-like domain deleted self-assembles into capsid particles but fails to bind nucleic acids. J Virol 1989; 63: 46454652.
  • 13
    Hatton T, Zhou S, Standring DN. RNA- and DNA-binding activities in hepatitis B virus capsid protein: a model for their roles in viral replication. J Virol 1992; 66: 52325241.
  • 14
    Nassal M. The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J Virol 1992; 66: 41074116.
  • 15
    Schlicht HJ, Bartenschlager R, Schaller H. The duck hepatitis B virus core protein contains a highly phosphorylated C terminus that is essential for replication but not for RNA packaging. J Virol 1989; 63: 29953000.
  • 16
    Yu M, Summers J. A domain of the hepadnavirus capsid protein is specifically required for DNA maturation and virus assembly. J Virol 1991; 65: 25112517.
  • 17
    Kalnins A, Otto K, Ruther U, Muller-Hill B. Sequence of the lacZ gene of Escherichia coli. EMBO J 1983; 2: 593597.
  • 18
    Mattes F, Tong S, Teubner K, Blum HE. Complete nucleotide sequence of a German duck hepatitis B virus. Nucleic Acids Res 1990; 18: 6140.
  • 19
    von Weizsäcker F, Wieland S, Blum HE. Identification of two separable modules in the duck hepatitis B virus core protein. J Virol 1995; 69: 27042707.
  • 20
    Chalfie MY, Tu Y, Euskirchen G, Ward WW, Prasher DC. Green fluorescent protein as a marker for gene expression. Science 1994; 263: 802805.
  • 21
    Blum HE, Galun E, Liang TJ, von Weizsäcker F, Wands JR. Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol 1991; 65: 18361842.
  • 22
    Condreay LD, Aldrich CE, Coates L, Mason WS, Wu TT. Efficient duck hepatitis B virus production by an avian liver tumor cell line. J Virol 1990; 64: 32493258.
  • 23
    Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Strahl K. Current protocols in molecular biology. New York: Wiley, 1996.
  • 24
    Gilboa E, Smith C. Gene therapy for infectious diseases: the AIDS model. Trends Genet 1994; 10: 139144.
  • 25
    Hélène C, Toulmé J-J. Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta 1990; 1049: 99125.
  • 26
    Baltimore D. Gene therapy. Intracellular immunization. Nature 1988; 335: 395396.